- Home
- CNTA vs BBU Comparison
CNTA vs BBU Comparison
Compare CNTA & BBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTA | BBU |
|---|---|---|
| Founded | 2020 | 2016 |
| Country | United Kingdom | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.1B |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CNTA | BBU |
|---|---|---|
| Price | $39.51 | $31.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $42.00 | $39.40 |
| AVG Volume (30 Days) | ★ 3.9M | 43.8K |
| Earning Date | 05-13-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.79% |
| EPS Growth | ★ 29.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.60 | $18.71 |
| 52 Week High | $40.26 | $37.75 |
Technical Indicators
Market Signals| Indicator | CNTA | BBU |
|---|---|---|
| Relative Strength Index (RSI) | 76.56 | 44.87 |
| Support Level | $24.80 | $29.90 |
| Resistance Level | N/A | $36.93 |
| Average True Range (ATR) | 1.33 | 1.38 |
| MACD | 1.25 | 0.23 |
| Stochastic Oscillator | 94.93 | 46.92 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About BBU Brookfield Business Partners L.P. Limited Partnership Units
Brookfield Business Partners LP is a business services and industrials company. It focused on operating businesses that are either low-cost producers and benefit from high barriers to entry. The company's operating segment includes Business services; Infrastructure services; Industrials and Corporate and other. It generates maximum revenue from the Business Services segment. Geographically operates in USA, Europe, Australia, Brazil, Canada, UK, Mexico and Other, majority of revenue is from UK.